Harvard Bioscience (HBIO) Return on Capital Employed Growth (1y) (2012 - 2026)
Harvard Bioscience (HBIO) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.13 Bn | 120.91 Bn | 1.96 Bn | 395.00 |
| 2 | Becton Dickinson | 44.77 Bn | 43.95 Bn | 2.15 Bn | 62.00 |
| 3 | Alcon | 33.17 Bn | 31.51 Bn | 1.53 Bn | - |
| 4 | Medline | 33.04 Bn | 30.81 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.35 Bn | 27.69 Bn | 890.98 Mn | 82.00 |
| 6 | West Pharmaceutical Services | 23.65 Bn | 23.21 Bn | 329.20 Mn | 142.00 |
| 7 | Solventum | 14.03 Bn | 13.47 Bn | 1.10 Bn | 1,267.00 |
| 8 | Cooper Companies | 13.90 Bn | 13.76 Bn | 735.40 Mn | -203.00 |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | -128.00 |
| 10 | Harvard Bioscience | 27.26 Mn | 20.16 Mn | 12.24 Mn | 11,240.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,240.00 |
| Dec 31, 2025 | -7,673.00 |
| Sep 30, 2025 | -19,847.00 |
| Jun 30, 2025 | -20,695.00 |
| Mar 31, 2025 | -11,061.00 |
| Dec 31, 2024 | -1,009.00 |
| Sep 30, 2024 | -652.00 |
| Jun 30, 2024 | -323.00 |
| Mar 31, 2024 | -320.00 |
| Dec 31, 2023 | 733.00 |
| Sep 30, 2023 | 467.00 |
| Jun 30, 2023 | -103.00 |
| Mar 31, 2023 | 456.00 |
| Dec 31, 2022 | -720.00 |
| Sep 30, 2022 | -608.00 |
| Jun 30, 2022 | -248.00 |
| Mar 31, 2022 | -576.00 |
| Dec 31, 2021 | 139.00 |
| Sep 30, 2021 | 309.00 |
| Jun 30, 2021 | 400.00 |